Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?news2025-12-02T10:04:46+00:00December 2nd, 2025|The New York Times|
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Findsnews2025-11-25T20:54:17+00:00November 25th, 2025|The New York Times|
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugsnews2025-11-14T10:02:07+00:00November 14th, 2025|The New York Times|
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
Cardiovascular Benefits of Wegovy Extend Beyond Weight Loss, Study Showsnews2025-10-22T22:30:06+00:00October 22nd, 2025|The New York Times|
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugsnews2025-10-05T19:47:27+00:00October 5th, 2025|The New York Times|
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertisernews2025-09-12T22:09:11+00:00September 12th, 2025|The New York Times|
Un fármaco común para perder peso puede tratar una enfermedad hepática grave, según la FDAnews2025-08-19T07:02:57+00:00August 19th, 2025|The New York Times|
Wegovy Gets F.D.A. Approval for MASHnews2025-08-18T17:21:18+00:00August 18th, 2025|The New York Times|
